Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BTAI

BioXcel Therapeutics Inc

Jun 10 • 04:00PM ET

1.09

+0.02 1.87 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Nano • NASD

Peers: INCR TLPH ZYBT CRDL DERM ANIK ASRT LFCR TKNO OPTH

| Held by: VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.19	Insider Own	4.63%	Shs Outstand	30.88M	Perf Week	-6.03%
Market Cap	33.66M	Forward P/E	-	EPS next Y	-1.53	Insider Trans	-2.70%	Shs Float	29.45M	Perf Month	-9.17%
Enterprise Value	116.77M	PEG	-	EPS next Q	-0.42	Inst Own	18.72%	Short Float	11.97%	Perf Quarter	-30.57%
Income	-75.33M	P/S	49.50	EPS this Y	70.90%	Inst Trans	-0.69%	Short Ratio	4.30	Perf Half Y	-50.45%
Sales	0.68M	P/B	-	EPS next Y	8.05%	ROA	-207.56%	Short Interest	3.53M	Perf YTD	-31.87%
Book/sh	-3.90	P/C	1.96	EPS next 5Y	48.34%	ROE	-	52W High	8.08 -86.51%	Perf Year	-45.23%
Cash/sh	0.56	P/FCF	-	EPS past 3/5Y	60.75% 37.62%	ROIC	-	52W Low	1.01 7.92%	Perf 3Y	-99.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	19.63% -	Gross Margin	-5.15%	Volatility	7.81% 6.77%	Perf 5Y	-99.82%
Dividend TTM	-	EV/Sales	171.72	EPS Y/Y TTM	54.23%	Oper. Margin	-7344.26%	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.61	Sales Y/Y TTM	-63.28%	Profit Margin	-11078.53%	RSI (14)	43.21	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	0.62	EPS Q/Q	64.12%	SMA20	-6.07%	Beta	0.32	Target Price	14.60
Payout	-	Debt/Eq	-	Sales Q/Q	22.62%	SMA50	-5.56%	Rel Volume	0.56	Prev Close	1.07
Employees	29	LT Debt/Eq	-	Earnings	May 15 BMO	SMA200	-42.26%	Avg Volume	819.50K	Price	1.09
IPO	Mar 08, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	-1.41% -46.00%	Trades		Volume	501,800	Change	1.87%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)